We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Committee Examines Drug Pricing For Government Healthcare Plans
House Committee Examines Drug Pricing For Government Healthcare Plans
February 16, 2007
Government healthcare programs must require more price transparency and better reporting to stop pharmaceutical companies from overcharging them for medications, according to experts and activists testifying at a recent House committee hearing.